Oramed Pharm's market cap is currently $89.49M. The company's EPS TTM is $0.109; its P/E ratio is 20.37; Oramed Pharm is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Sep 21	Sep 20	Sep 19
Income Statement
Total Revenue	$ 1.34M	$ 2.70M	$ 2.70M	$ 2.71M	$ 2.70M
Gross Profit	$ 1.34M	$ 2.70M	$ 2.70M	$ 2.62M	$ 2.61M
Operating Income	$ -15.77M	$ -40.60M	$ -24.22M	$ -11.76M	$ -14.63M
EBITDA	$ -15.57M	$ -36.98M	$ -25.04M	$ -11.31M	$ -14.17M
Net Income	$ 5.53M	$ -37.76M	$ -22.24M	$ -11.51M	$ -14.36M
Balance Sheet
Cash & Short-Term Investments	$ 162.05M	$ 155.72M	$ 94.14M	$ 39.90M	$ 32.28M
Total Assets	$ 220.55M	$ 161.64M	$ 128.00M	$ 44.63M	$ 34.66M
Total Debt	$ 51.62M	$ 894.00K	$ 533.00K	$ 75.00K	$ 0.00
Net Debt	$ 42.57M	$ -39.57M	$ -76.71M	$ -19.22M	$ -3.33M
Total Liabilities	$ 57.66M	$ 10.49M	$ 11.48M	$ 11.75M	$ 15.27M
Stockholders' Equity	$ 163.82M	$ 151.81M	$ 115.77M	$ 32.88M	$ 19.39M
Cash Flow
Free Cash Flow	$ -10.55M	$ -28.41M	$ -21.56M	$ -12.52M	$ -12.96M
Operating Cash Flow	$ -10.29M	$ -27.92M	$ -21.18M	$ -12.44M	$ -12.94M
Investing Cash Flow	$ -73.04M	$ 30.21M	$ -23.76M	$ 4.63M	$ 11.26M
Financing Cash Flow	$ 51.98M	$ 10.78M	$ 102.89M	$ 23.79M	$ 0.00

Currency in USD

Oramed Pharm Earnings and Revenue History

Income Statement >

Oramed Pharm Debt to Assets

Balance Sheet >

Oramed Pharm Cash Flow

Cash Flow >

Oramed Pharm Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing